NO904800L - Fremgangsmaate for fremstilling av terapeutisk aktive karbamater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive karbamater.

Info

Publication number
NO904800L
NO904800L NO90904800A NO904800A NO904800L NO 904800 L NO904800 L NO 904800L NO 90904800 A NO90904800 A NO 90904800A NO 904800 A NO904800 A NO 904800A NO 904800 L NO904800 L NO 904800L
Authority
NO
Norway
Prior art keywords
procedure
preparation
therapeutic active
active carbamates
carbamates
Prior art date
Application number
NO90904800A
Other languages
English (en)
Other versions
NO904800D0 (no
Inventor
Patrick Michael O'brien
Drago Robert Sliskovic
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO904800D0 publication Critical patent/NO904800D0/no
Publication of NO904800L publication Critical patent/NO904800L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
NO90904800A 1989-11-06 1990-11-05 Fremgangsmaate for fremstilling av terapeutisk aktive karbamater. NO904800L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43283589A 1989-11-06 1989-11-06
US07/584,326 US5142094A (en) 1989-11-06 1990-09-18 Aryl substituted carbamate derivatives which are acat inhibitors

Publications (2)

Publication Number Publication Date
NO904800D0 NO904800D0 (no) 1990-11-05
NO904800L true NO904800L (no) 1991-05-07

Family

ID=27029647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904800A NO904800L (no) 1989-11-06 1990-11-05 Fremgangsmaate for fremstilling av terapeutisk aktive karbamater.

Country Status (12)

Country Link
US (1) US5142094A (no)
EP (1) EP0431321A1 (no)
JP (1) JPH03218345A (no)
CN (1) CN1051552A (no)
AU (1) AU6577790A (no)
CA (1) CA2029337A1 (no)
FI (1) FI905477A0 (no)
HU (1) HU907033D0 (no)
IE (1) IE903980A1 (no)
IL (1) IL96013A0 (no)
NO (1) NO904800L (no)
PT (1) PT95797A (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362878A (en) * 1991-03-21 1994-11-08 Pfizer Inc. Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
US5952354A (en) * 1993-07-21 1999-09-14 American Home Products Corporation Tris carbamic acid esters: inhibitors of cholesterol absorption
WO1997001533A1 (fr) * 1995-06-27 1997-01-16 The Green Cross Corporation Derives d'acide thiocarbamique
WO1998002412A1 (fr) * 1996-07-12 1998-01-22 Yamanouchi Pharmaceutical Co., Ltd. Derives de propionanilide ou sels de ceux-ci
WO1998057929A1 (en) * 1997-06-16 1998-12-23 American Home Products Corporation Elevation of hdl cholesterol by n-[4-[ (aminothioxomethyl) hydrazono] -4-arylbutyl]amides
AU7589498A (en) * 1997-06-16 1999-01-04 American Home Products Corporation Elevation of hdl cholesterol by 4-{(aminothioxomethyl)hydrazono}-4-arylbutyl carbamates
WO1998057925A1 (en) * 1997-06-16 1998-12-23 American Home Products Corporation Elevation of hdl cholesterol by 2-[(aminothioxomethyl)-hydrazono]-2-arylethyl carbamates
WO1999025682A1 (en) * 1997-11-17 1999-05-27 American Home Products Corporation Elevation of hdl cholesterol by 4-[(aminothioxomethyl) -hydrazono] -n-(substituted) -4-arylbutanamides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1434826A (en) * 1973-11-14 1976-05-05 Gallardo Antonio Sa Esters and carbamates of aminoalkanols
US4315861A (en) * 1979-11-08 1982-02-16 Chinoin Gyogyszer RT Process for O-acylating phenol derivatives and acylating compositions for this purpose
NZ200242A (en) * 1981-04-16 1985-08-30 Sumitomo Chemical Co N-phenyl carbamates and fungicidal compositions

Also Published As

Publication number Publication date
CN1051552A (zh) 1991-05-22
US5142094A (en) 1992-08-25
IL96013A0 (en) 1991-07-18
CA2029337A1 (en) 1991-05-07
AU6577790A (en) 1991-05-09
FI905477A0 (fi) 1990-11-05
PT95797A (pt) 1991-09-30
JPH03218345A (ja) 1991-09-25
EP0431321A1 (en) 1991-06-12
HU907033D0 (en) 1991-05-28
IE903980A1 (en) 1991-05-08
NO904800D0 (no) 1990-11-05

Similar Documents

Publication Publication Date Title
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO912672L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oligomerer.
NO905201D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzofuran-derivater.
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO874869L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO900032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO890155D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO910874D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO900697D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater.
NO891723L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO914071D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO904800D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamater.
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
NO894423D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanolaminer.
NO900972L (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO883959L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.